Abstract

B lymphocyte activation is regulated by its membrane-bound B cell receptors (BCRs) upon recognizing diverse antigens. It is hypothesized that antigen binding would trigger conformational changes within BCRs, followed by a series of downstream signaling activation. To measure the BCR conformational changes in live cells, a fluorescent site-specific labeling technique is preferred. Genetically encoded fluorescent tags visualize the location of the target proteins. However, these fluorescent proteins are large (~30 kDa) and would potentially perturb the conformation of BCRs. Here, we describe the general procedures of utilizing short tag-based site-specific labeling methodologies combining with fluorescence resonance energy transfer (FRET) assay to monitor the conformational changes within BCR extracellular domains upon antigen engagement.

Highlights

  • [Background] B lymphocytes are responsible for the production of protective antibodies against pathology arising from the recognition of antigens by the cell membrane expressed B cell receptors (BCRs)

  • fluorescein arsenical hairpin binder (FlAsH) emits green-yellow fluorescence, while the color variant, resorufin arsenical hairpin binder (ReAsH) fluorescence peaks in the red (609 nm), would serve as a Fluorescence resonance energy transfer (FRET) acceptor for green fluorescent signal, such as Coenzyme A (CoA)-488

  • We describe the procedures to label the BCRs and soluble Ig by inserting the ybbR tag and tetracysteine tag in BCR molecule, as well as the usage of necessary components to set up the site-special labeling system

Read more

Summary

Introduction

[Background] B lymphocytes are responsible for the production of protective antibodies against pathology arising from the recognition of antigens by the cell membrane expressed B cell receptors (BCRs). In terms of the heavy chain of IgM-BCR, it includes 4 domains, Cμ1, Cμ2, Cμ3, and Cμ4 (Figure 1). Variable domains in the heavy and light chain polypeptides form an antigen-binding site unique to the antibody.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.